Rare Disease Launch
When you’re preparing for commercialisation without infrastructure — and need funding, direction, and team alignment
The Challenge.
A biotech was preparing for a rare disease launch with strong science, but no commercial infrastructure. With Series C funding on the line and a 36-month window, the leadership team needed an executable roadmap — and confidence it would hold under pressure.
What We Did.
- Launch audit and investor GTM narrative
- Cross-functional roadmap and milestone governance
- Embedded interim leadership and functional coaching
- Percepta Vision™ to assess team readiness
Impact.
- Series C funding secured
- 92% of launch milestones delivered on plan
- Roadmap adopted by board
- Readiness score increased by 22% in 6 months